Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
139.70
Change Change %
-2.60 -1.83%

Updated:20 Feb, 2020, 15:55 PM IST

BSE
140.00
Change Change %
-2.65 -1.86%

Updated:20 Feb, 2020, 16:01 PM IST

Bliss GVS Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18 MAR'17
Operational & Financial Ratios:
   Earnings Per Share (Rs) 5.53 5.73
   DPS(Rs) 1.00 0.60
   Book NAV/Share(Rs) 52.49 47.66
Margin Ratios:
   Yield on Advances 0.00 0.00
   Yield on Investments 0.00 0.00
   Cost of Liabilities 0.00 0.00
   NIM 0.00 0.00
   Interest Spread 0.00 0.00
Performance Ratios:
   ROA(%) 8.38 8.67
   ROE(%) 11.04 12.80
   ROCE(%) 15.60 19.25
Efficiency Ratios:
   Cost Income Ratio 0.00 0.00
   Core Cost Income Ratio 0.00 0.00
   Operating Costs to Assets 0.00 0.00
Capitalisation Ratios:
   Tier 1 ratio 0.00 0.00
   Tier 2 ratio 0.00 0.00
   CAR 0.00 0.00
Valuation Parameters:
   PER(x) 35.34 30.77
   PCE(x) 32.14 28.10
   Price / Book(x) 3.72 3.70
   Yield(%) 0.51 0.34
   EV / Net Sales(x) 6.84 5.20
   EV / Core EBITDA(x) 20.50 16.53
   EV / EBIT(x) 21.74 17.42
   EV / CE(x) 2.94 2.72
   M Cap / Sales 6.76 5.23
Growth Ratio:
   Core Operating Income Growth -23.39 -32.92
   Operating Profit Growth -9.26 -8.35
   Net Profit Growth -3.58 -9.88
   BVPS Growth 10.13 13.79
   Advances Growth 0.00 0.00
   EPS Growth(%) -3.58 -9.88
Liquidity Ratios:
   Loans / Deposits(x) 0.00 0.00
   Total Debt / Equity(x) 0.00 0.00
   Current Ratio(x) 0.00 0.00
   Quick Ratio(x) 0.00 0.00
   Total Debt / Mcap(x) 0.00 0.00
   Net NPA in Rs. Million 0.00 0.00
Top